Polycystic ovary syndrome - targeting the sympathetic nervous system to improve outcomes

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Polycystic ovary syndrome (PCOS) affects approximately 10% of women of reproductive age, rendering it a major public health issue. Due to the combined development of abdominal obesity, hypertension and insulin resistance patients with PCOS are at increased risk of developing heart disease. The etiology of PCOS remains unknown but work by us implicates involvement of the sympathetic nervous system. We aim to elucidate the role of the sympathetic nervous system in PCOS and to examine the effect of pharmacological treatment targeting this system.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $353,140.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Endocrinology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

insulin resistance | metabolic disorders | polycystic ovarian syndrome (PCOS) | sympathetic nervous system | women's health